Modulators of toll-like receptors
US-11110091-B2 · Sep 7, 2021 · US
US9127006B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9127006-B2 |
| Application number | US-201414321689-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 1, 2014 |
| Priority date | Dec 9, 2008 |
| Publication date | Sep 8, 2015 |
| Grant date | Sep 8, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are modulators of TLRs of Formula II: pharmaceutically acceptable salts thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
Opening claim text (preview).
We claim: 1. A compound having the structure: or a pharmaceutically acceptable salt thereof, wherein: L 1 is —NH— or —O—; R 1 is C 1 -C 6 alkyl, C 1 -C 6 heteroalkyl, C 3 -C 20 heterocyclylalkyl, or C 4 -C 20 carbocyclylalkyl, wherein the heteroalkyl group containing one or more heteroatoms selected from O, N and S, and wherein the heterocyclyl group containing 1 to 4 heteroatoms selected from N, O and S; each of R 4 and R 5 independently is H or C 1 -C 6 alkyl; X 1 is C 1 -C 6 alkylene, or C 1 -C 6 heteroalkylene; D is phenyl, biphenyl or pyridinyl, wherein said phenyl, biphenyl or pyridinyl is substituted with -L 2 -NR 6 R 7 ; or D is pyridinyl, piperidinyl, piperazinyl or 1,2,3,4-tetrahydroisoquinolinyl; n is 0 or 1; R 3 is selected from the group consisting of cyano, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, —CHO, or C 4 -C 20 carbocyclylalkyl; and L 2 is C 1 -C 6 alkylene or a covalent bond; each of R 6 and R 7 independently is H, or C 1 -C 6 alkyl; or R 6 and R 7 taken together with the nitrogen to which they are attached form an unsubstituted 4-6 membered heterocycle containing 0 to 2 additional heteroatoms selected from N, O and S. 2. The compound of claim 1 , wherein X 1 is —CH 2 —. 3. The compound of claim 1 , wherein D is phenyl or biphenyl. 4. The compound of claim 1 , wherein D is pyridinyl. 5. The compound of claim 1 , wherein L 2 is —CH 2 —. 6. The compound of claim 1 , wherein L 1 is —O—. 7. The compound of claim 1 , selected from the group consisting of: or a pharmaceutically acceptable salt thereof. 8. The compound of claim 1 , having the structure: or a pharmaceutically acceptable salt thereof.
Related publications grouped by family.
Answers are generated from the same data shown on this page.